SZC Versus SPS for Treatment of Hyperkalemia in Hemodialysis Patients
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Marwa Ahmed Abdelrahman, MD
consultant
Study Chair - Mohamed Aly Abdelhalim, MD
Lecturer
Study Chair - Mohamed Mamdouh Elsayed, MD
lecturer
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Faculty of Medicine, Aexandria University
Alexandria, Egypt
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Jan 2024
- Primary completion
- 15 Oct 2024
- Completion
- 15 Dec 2024
- Last update posted
- 11 Feb 2025
- Registered enrollment
- 120
- Registry id
- NCT06029179
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.